| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 57.1044 | 62 |
| GSM780708 | Untreated after 4 days (C2_1) | 57.1085 | 62 |
| GSM780709 | Untreated after 4 days (C3_1) | 49.7942 | 48 |
| GSM780719 | Untreated after 4 days (C1_2) | 52.3511 | 55 |
| GSM780720 | Untreated after 4 days (C2_2) | 51.5789 | 53 |
| GSM780721 | Untreated after 4 days (C3_2) | 40.8313 | 9 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.8033 | 53 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.3909 | 38 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 55.4446 | 60 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 53.9069 | 58 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 41.0749 | 10 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 53.6808 | 57 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 53.1388 | 56 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 57.4928 | 62 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 55.695 | 60 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.3945 | 29 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.8492 | 44 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 59.4381 | 64 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 59.5505 | 64 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 54.0646 | 58 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 53.0498 | 56 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 51.7298 | 53 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 55.9501 | 61 |